Astrotech Corporation Reports Revenue Decline and Increased Net Loss for Three and Nine Months Ended March 31, 2026

Astrotech Corporation reported a decline in financial performance for the three and nine months ended March 31, 2026, as detailed in its latest 10-Q filing. The company generated revenue of $343,000 for the three months, down from $534,000 in the same period last year, and $787,000 for the nine months, compared to $829,000 in the prior year. The decrease in revenue was attributed primarily to lower product sales and negative grant revenue, although there was an increase in consumables revenue. The gross profit for the three months was $67,000, reflecting a gross margin of 20%, a significant drop from 44% in the previous year, while the nine-month gross profit was $262,000, with a gross margin of 33%, down from 48%.

Operating expenses decreased by 14.2% to $3.52 million for the three months ended March 31, 2026, compared to $4.10 million in the prior year, driven by reduced research and development costs as the company shifted focus towards sales initiatives. The net loss for the quarter was $3.77 million, slightly higher than the $3.63 million loss reported in the same quarter of 2025. For the nine-month period, the net loss was $11.16 million, compared to $10.92 million in the previous year. The company’s accumulated deficit reached approximately $262 million as of March 31, 2026.

In terms of strategic developments, Astrotech has been focusing on expanding its product offerings and market presence. The company has made significant strides with its TRACER 1000 explosives trace detector, which has been certified for use in various international markets. As of March 31, 2026, the TRACER 1000 was deployed in approximately 37 locations across 16 countries. Additionally, the company is advancing its AgLAB 1000 series for the hemp and cannabis markets, which aims to optimize yields in distillation processes. The company has also formed new subsidiaries, including Pro-Control and EN-SCAN, to leverage its mass spectrometry technology in industrial process control and environmental testing, respectively.

Operationally, Astrotech reported cash and cash equivalents of $2.68 million and short-term investments of $3.90 million as of March 31, 2026. The company has positive working capital of approximately $9.5 million, although it has incurred recurring losses and negative cash flows from operations since inception. The company’s management believes that its current cash reserves, along with potential capital-raising activities, will support its operational plans for at least the next 12 months. However, substantial additional capital will be required for long-term growth and operational objectives, and the company is actively monitoring potential financing sources.

Looking ahead, Astrotech's management has expressed cautious optimism regarding its ability to generate sales from existing and future business opportunities. The company is focused on enhancing its product offerings and expanding its market reach, particularly in the security and environmental sectors. However, management acknowledges the challenges posed by market conditions, competition, and the need for additional capital to sustain operations and achieve growth objectives.